Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

RETOUCH CLINIC ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   5.8% 5.0% 2.3% 1.7% 1.5% 1.5% 11.1% 11.1%   Credit score (0-100)   41 44 63 72 75 77 22 22   Credit rating   BBB BBB BBB A A A BB BB   Credit limit (kDKK)   0.0 0.0 0.1 5.6 24.3 29.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,664 6,830 8,056 8,548 8,057 9,216 0.0 0.0   EBITDA   1,894 2,956 2,731 2,143 1,809 2,679 0.0 0.0   EBIT   1,737 2,758 2,314 1,522 991 1,439 0.0 0.0   Pre-tax profit (PTP)   1,719.2 2,756.4 2,151.5 1,452.1 810.4 1,129.8 0.0 0.0   Net earnings   1,318.0 2,153.4 1,707.7 1,100.4 594.7 847.3 0.0 0.0   Pre-tax profit without non-rec. items   1,719 2,756 2,152 1,452 810 1,130 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   687 904 1,525 1,751 2,172 3,889 0.0 0.0   Shareholders equity total   1,598 2,763 3,521 3,871 3,595 4,442 4,392 4,392   Interest-bearing liabilities   186 78.6 9.1 2,278 2,641 4,054 0.0 0.0   Balance sheet total (assets)   3,512 5,376 6,853 8,357 8,084 10,914 4,392 4,392   Net Debt   -684 -1,817 -514 1,939 2,438 3,757 -4,392 -4,392     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,664 6,830 8,056 8,548 8,057 9,216 0.0 0.0   Gross profit growth   61.9% 20.6% 17.9% 6.1% -5.7% 14.4% -100.0% 0.0%   Employees   7 7 12 11 11 8 0 0   Employee growth %   40.0% 0.0% 71.4% -8.3% 0.0% -27.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,512 5,376 6,853 8,357 8,084 10,914 4,392 4,392   Balance sheet change%   45.1% 53.1% 27.5% 22.0% -3.3% 35.0% -59.8% 0.0%   Added value   1,893.6 2,956.5 2,730.7 2,143.4 1,611.9 2,679.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -8 279 282 -128 -130 521 -4,805 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   30.7% 40.4% 28.7% 17.8% 12.3% 15.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   58.5% 62.1% 37.8% 20.5% 12.1% 15.5% 0.0% 0.0%   ROI %   112.5% 111.0% 69.0% 31.0% 15.6% 19.6% 0.0% 0.0%   ROE %   110.9% 98.8% 54.3% 29.8% 15.9% 21.1% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   48.7% 53.6% 53.2% 49.7% 48.2% 41.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -36.1% -61.5% -18.8% 90.5% 134.8% 140.2% 0.0% 0.0%   Gearing %   11.6% 2.8% 0.3% 58.8% 73.5% 91.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7.4% 1.5% 370.0% 9.2% 7.3% 10.3% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.7 1.0 0.8 0.8 0.4 0.9 0.0 0.0   Current Ratio   1.3 1.5 1.4 1.3 0.9 1.3 0.0 0.0   Cash and cash equivalent   870.2 1,896.1 522.8 339.2 203.2 296.5 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   603.2 1,332.3 1,260.8 1,142.2 -358.7 1,346.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   271 422 228 195 147 335 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   271 422 228 195 164 335 0 0   EBIT / employee   248 394 193 138 90 180 0 0   Net earnings / employee   188 308 142 100 54 106 0 0